Skip Main Navigation Links Jump to Footer
Proceedings of the National Academy of Sciences of the United States of AmericaVolume 98, Issue 1, 2 January 2001, Pages 75-80

Tailoring in vitro evolution for protein affinity or stability(Article)

  • aBiochemisches Institut, Universität Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland
  • bCambridge Antibody Technology, Science Park, Melbourn, Cambridgeshire SG8 6JJ, United Kingdom
  • cEvotec Neurosciences GmbH, Schnackenburgallee 114, 22525 Hamburg, Germany

Abstract

We describe a rapid and general technology working entirely in vitro to evolve either the affinity or the stability of ligand-binding proteins, depending on the chosen selection pressure. Tailored in vitro selection strategies based on ribosome display were combined with in vitro diversification by DNA shuffling to evolve either the off-rate or thermodynamic stability of single-chain Fv antibody fragments (scFvs). To demonstrate the potential of this method, we chose to optimize two proteins already possessing favorable properties. A scFv with an initial affinity of 1.1 nM (koff at 4°C of 10-4 s-1) was improved 30-fold by the use of off-rate selections over a period of several days. As a second example, a generic selection strategy for improved stability exploited the property of ribosome display that the conditions can be altered under which the folding of the displayed protein occurs. We used decreasing redox potentials in the selection step to select for molecules stable in the absence of disulfide bonds. They could be functionally expressed in the reducing cytoplasm, and, when allowed to form disulfides again, their stability had increased to 54 kJ/mol from an initial value of 24 kJ/mol. Sequencing revealed that the evolved mutant proteins had used different strategies of residue changes to adapt to the selection pressure. Therefore, by a combination of randomization and appropriate selection strategies, an in vitro evolution of protein properties in a predictable direction is possible.

Indexed keywords

EMTREE drug terms:antibodymutant protein
EMTREE medical terms:articlebinding affinitycontrolled studydisulfide bondevolutionin vitro studynonhumanoxidation reduction reactionpriority journalprotein bindingprotein foldingprotein stabilityribosomethermodynamics
  • ISSN: 00278424
  • CODEN: PNASA
  • Source Type: Journal
  • Original language: English
  • DOI: 10.1073/pnas.98.1.75
  • PubMed ID: 11134506
  • Document Type: Article
  • Publisher: National Academy of Sciences

  Plückthun, A.; Biochemisches Institut, Universität Zürich, Winterthurerstrasse 190, Switzerland;
© Copyright 2018 Elsevier B.V., All rights reserved.

Cited by 203 documents

Kennedy, P.J. , Oliveira, C. , Granja, P.L.
Monoclonal antibodies: technologies for early discovery and engineering
(2018) Critical Reviews in Biotechnology
Liu, W. , Song, H. , Chen, Q.
Recent advances in the selection and identification of antigen-specific nanobodies
(2018) Molecular Immunology
Dreier, B. , Plückthun, A.
Rapid selection of high-affinity antibody scfv fragments using ribosome display
(2018) Methods in Molecular Biology
View details of all 203 citations